$YCBD
cbdMD, Inc. Stock $ycbd

$ycbd Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-K Financial Statement

#000143774924037840 Filed on December 18, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2024
Revenue			$19.48M
YoY Change			-19.35%
Cost Of Revenue			$7.487M
YoY Change			-18.43%
Gross Profit			$12.00M
YoY Change			-19.91%
Gross Profit Margin			61.57%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$452.3K
YoY Change			11.88%
% of Gross Profit			3.77%
Operating Expenses
YoY Change
Operating Profit			-$3.315M
YoY Change			-85.26%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income			-$3.700M
YoY Change			-83.87%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		-$152.8K	-$3.700M
YoY Change		-99.04%	-83.87%
Net Earnings / Revenue			-18.99%
Basic Earnings Per Share			-$1.79
Diluted Earnings Per Share			-$1.79
COMMON SHARES
Basic Shares Outstanding	5.539M	3.763M	4.313M
Diluted Shares Outstanding			4.313M

Balance Sheet

Concept	2024 Q4	2024 Q3	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$2.453M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory		$2.524M
Prepaid Expenses
Receivables		$621.7K
Other Receivables
Total Short-Term Assets		$6.389M
YoY Change		-20.83%
LONG-TERM ASSETS
Property, Plant & Equipment		$454.3K
YoY Change		-36.61%
Goodwill
YoY Change
Intangibles		$2.890M
YoY Change		-10.24%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$4.192M
YoY Change		-48.4%
TOTAL ASSETS
Total Short-Term Assets		$6.389M
Total Long-Term Assets		$4.192M
Total Assets		$10.58M
YoY Change		-34.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$1.541M
YoY Change		-19.16%
Accrued Expenses		$632.7K
YoY Change		-57.38%
Deferred Revenue		$503.3K
YoY Change		167.98%
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$8.618M
YoY Change		84.53%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities		$8.618M
Total Long-Term Liabilities		$0.00
Total Liabilities		$8.618M
YoY Change		20.3%
SHAREHOLDERS EQUITY
Retained Earnings		-$182.1M
YoY Change		4.42%
Common Stock		$3.939K
YoY Change		33.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$1.963M
YoY Change
Total Liabilities & Shareholders Equity		$10.58M
YoY Change		-34.66%

Cashflow Statement

Concept	2024 Q3	2024
OPERATING ACTIVITIES
Net Income	-$152.8K	-$3.700M
YoY Change	-99.04%	-83.87%
Depreciation, Depletion And Amortization		$452.3K
YoY Change		11.88%
Cash From Operating Activities		-$352.8K
YoY Change		-91.8%
INVESTING ACTIVITIES
Capital Expenditures		$190.0K
YoY Change		-36.14%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$290.0K
YoY Change		-141.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$50.00K
YoY Change		-97.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$1.298M
YoY Change		-198.09%
NET CHANGE
Cash From Operating Activities		-$352.8K
Cash From Investing Activities		-$290.0K
Cash From Financing Activities		$1.298M
Net Change In Cash		$654.7K
YoY Change		-113.3%
FREE CASH FLOW
Cash From Operating Activities		-$352.8K
Capital Expenditures		$190.0K
Free Cash Flow		-$542.8K
YoY Change		-88.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Entity Registrant Name EntityRegistrantName	cbdMD, Inc.
CY2023Q3	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	750000	usd
CY2024Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	-0	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	-0	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	95000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	857000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	17731000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	16510000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17731000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16510000	usd
CY2024Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2018Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	2100000	usd
CY2018Q3	ycbd	Deferred Tax Asset And Related Valuation Allowance DeferredTaxAssetAndRelatedValuationAllowance	500000	usd
CY2024Q3	ycbd	Deferred Tax Asset And Related Valuation Allowance DeferredTaxAssetAndRelatedValuationAllowance	69100000	usd
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001644903
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ycbd	Longterm Debt Excluding Convertible Notes Noncurrent LongtermDebtExcludingConvertibleNotesNoncurrent		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000000
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	5000000
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3939057
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3939057
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2960573
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2960573
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3939057
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2960573
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-38299
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NC
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3414576
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	2101 Westinghouse Blvd., Suite A
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Charlotte
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28273
CY2024	dei	City Area Code CityAreaCode	704
CY2024	dei	Local Phone Number LocalPhoneNumber	445-3060
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Public Float EntityPublicFloat	2832040	usd
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5539124
CY2024	dei	Auditor Firm AuditorFirmId	677
CY2024	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2024	dei	Auditor Location AuditorLocation	Charlotte, North Carolina
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2452553	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1797860	usd
CY2024Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	983910	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1216090	usd
CY2024Q3	us-gaap	Inventory Gross InventoryGross	2365187	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	4052972	usd
CY2024Q3	ycbd	Prepaid Inventory PrepaidInventory	159006	usd
CY2023Q3	ycbd	Prepaid Inventory PrepaidInventory	182675	usd
CY2024Q3	ycbd	Prepaid Sponsorship PrepaidSponsorship	21754	usd
CY2023Q3	ycbd	Prepaid Sponsorship PrepaidSponsorship	70061	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	406674	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	750383	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	6389084	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8070041	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	454268	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	716579	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85817	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3350865	usd
CY2024Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	62708	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	138708	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2889580	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3219090	usd
CY2024Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	700000	usd
CY2023Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	700000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	4192373	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	8125242	usd
CY2024Q3	us-gaap	Assets Assets	10581457	usd
CY2023Q3	us-gaap	Assets Assets	16195283	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1541108	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1906319	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	632674	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	632195	usd
CY2024Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	4671000	usd
CY2023Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	667000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	503254	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	185246	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	98696	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1277089	usd
CY2024Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1171308	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	0	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2492	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8618040	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4670341	usd
CY2023Q3	ycbd	Longterm Debt Excluding Convertible Notes Noncurrent LongtermDebtExcludingConvertibleNotesNoncurrent	9	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2403286	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	90363	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2493658	usd
CY2024Q3	us-gaap	Liabilities Liabilities	8618040	usd
CY2023Q3	us-gaap	Liabilities Liabilities	7163999	usd
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	3939	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2961	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	184029565	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	183387095	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7189	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-182067898	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-174363772	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1963417	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9031284	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10581457	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16195283	usd
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19922319	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	25053857	usd
CY2024	ycbd	Sales Allowances SalesAllowances	440152	usd
CY2023	ycbd	Sales Allowances SalesAllowances	898495	usd
CY2024	us-gaap	Revenues Revenues	19482167	usd
CY2023	us-gaap	Revenues Revenues	24155362	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	7486626	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	9177703	usd
CY2024	us-gaap	Gross Profit GrossProfit	11995541	usd
CY2023	us-gaap	Gross Profit GrossProfit	14977659	usd
CY2024	ycbd	Operating Expenses Excluding Impairment OperatingExpensesExcludingImpairment	15310951	usd
CY2023	ycbd	Operating Expenses Excluding Impairment OperatingExpensesExcludingImpairment	24246208	usd
CY2024	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	13219000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-3315410	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-22487549	usd
CY2024	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2023	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-700000	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-74580	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-185638	usd
CY2024	ycbd	Fair Value Adjustment Of Debt FairValueAdjustmentOfDebt	-429789	usd
CY2023	ycbd	Fair Value Adjustment Of Debt FairValueAdjustmentOfDebt	0	usd
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-29507	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	63702	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3700126	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22938209	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3700126	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22938209	usd
CY2024	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4004001	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002000	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7704127	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26940209	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.79
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.32
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4312546
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2022320
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3700126	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22938209	usd
CY2024	ycbd	Comprehensive Income Loss Net Of Tax Attributable To Parent Before Income Adjustments ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments	-3700126	usd
CY2023	ycbd	Comprehensive Income Loss Net Of Tax Attributable To Parent Before Income Adjustments ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments	-22938209	usd
CY2024	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4004001	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002000	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7704127	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26940209	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3700126	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22938209	usd
CY2024	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	5015	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	233666	usd
CY2024	us-gaap	Restricted Stock Expense RestrictedStockExpense	11885	usd
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	109202	usd
CY2024	ycbd	Write Off Of Prepaid Assets WriteOffOfPrepaidAssets	0	usd
CY2023	ycbd	Write Off Of Prepaid Assets WriteOffOfPrepaidAssets	884892	usd
CY2024	us-gaap	Inventory Write Down InventoryWriteDown	921314	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	175499	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	697510	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1396459	usd
CY2024	us-gaap	Depreciation Depreciation	452326	usd
CY2023	us-gaap	Depreciation Depreciation	404280	usd
CY2024	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	13219000	usd
CY2024	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-74580	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-185638	usd
CY2024	ycbd	Fair Value Adjustment Of Debt FairValueAdjustmentOfDebt	-429789	usd
CY2023	ycbd	Fair Value Adjustment Of Debt FairValueAdjustmentOfDebt	-0	usd
CY2024	ycbd	Otherthantemporary Impairments On Other Investments OtherthantemporaryImpairmentsOnOtherInvestments	0	usd
CY2023	ycbd	Otherthantemporary Impairments On Other Investments OtherthantemporaryImpairmentsOnOtherInvestments	700000	usd
CY2024	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-696280	usd
CY2023	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
CY2024	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	670621	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1126976	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-232180	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-278482	usd
CY2024	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-76000	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-105898	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-766472	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-27443	usd
CY2024	ycbd	Increase Decrease In Prepaid Inventory Total IncreaseDecreaseInPrepaidInventoryTotal	-23670	usd
CY2023	ycbd	Increase Decrease In Prepaid Inventory Total IncreaseDecreaseInPrepaidInventoryTotal	-328784	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-396311	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2095323	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1124141	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1290141	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1151326	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1178683	usd
CY2024	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	318008	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	203341	usd
CY2024	ycbd	Collection On Discontinued Operations Accounts Receivable CollectionOnDiscontinuedOperationsAccountsReceivable	0	usd
CY2023	ycbd	Collection On Discontinued Operations Accounts Receivable CollectionOnDiscontinuedOperationsAccountsReceivable	1375	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-352792	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4302051	usd
CY2024	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	1000000	usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	100000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-0	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	190015	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	297549	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-290015	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	702451	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50001	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2478325	usd
CY2024	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	1247499	usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-132599	usd
CY2024	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	-0	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3668500	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1297500	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1322774	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	654693	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4922374	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1797860	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6720234	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2452553	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1797860	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	74638	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	6399	usd
CY2024	ycbd	Issuance Of Shares For Conversion Of Debt And Accrued Interest IssuanceOfSharesForConversionOfDebtAndAccruedInterest	515601	usd
CY2023	ycbd	Issuance Of Shares For Conversion Of Debt And Accrued Interest IssuanceOfSharesForConversionOfDebtAndAccruedInterest	0	usd
CY2024	us-gaap	Stock Issued1 StockIssued1	40725	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2024	ycbd	Preferred Dividends Accrued Not Yet Paid PreferredDividendsAccruedNotYetPaid	4004001	usd
CY2023	ycbd	Preferred Dividends Accrued Not Yet Paid PreferredDividendsAccruedNotYetPaid	667000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9031284	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	689	usd
CY2023Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000501	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-996501	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	7036743	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15783	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	303	usd
CY2024Q1	ycbd	Other Comprehensive Income Loss Changes In Fair Value Of Debt Related To Credit Risk OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk	6000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000500	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3010562	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3086847	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5.376	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	7.167	usd
CY2024Q2	ycbd	Other Comprehensive Income Loss Changes In Fair Value Of Debt Related To Credit Risk OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk	-4800	usd
CY2024Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000500	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	459737	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	3028121	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1.08	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	3.727	usd
CY2024Q3	ycbd	Other Comprehensive Income Loss Changes In Fair Value Of Debt Related To Credit Risk OtherComprehensiveIncomeLossChangesInFairValueOfDebtRelatedToCreditRisk	5989	usd
CY2024Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1002500	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-152798	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1963417	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31424431	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	43449	usd
CY2022Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000502	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3956062	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	26590761	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	56801	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1400000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	30000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	1
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000500	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1336802	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	25786224	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	69615	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4845	usd
CY2023Q2	ycbd	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits	0	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000501	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1770404	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	25731723	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-112	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	33171	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	3996	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000497	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15874941	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9031284	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are <em style="font: inherit;">not</em> limited to, allowances for doubtful accounts, inventory valuation reserves, certain assumptions related to the valuation of investments other securities, and acquired intangible and long-lived assets and the recoverability of intangible and long-lived assets. Actual results could differ from these estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	346197	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	42180	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	621678	usd
CY2024	us-gaap	Revenues Revenues	19482167	usd
CY2023	us-gaap	Revenues Revenues	24155362	usd
CY2024	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	4200000	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6000000	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Concentrations</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (“FDIC”) covers <em style="font: inherit;">$250,000</em> for substantially all depository accounts. The Company from time to time <em style="font: inherit;"> may </em>have amounts on deposit in excess of the insured limits. The Company had a $1,893,606 uninsured balance at <em style="font: inherit;"> September 30, 2024</em> and a $1,163,360 uninsured balance at <em style="font: inherit;"> September 30, 2023</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did <span style="-sec-ix-hidden:c121825261">not</span> have any customers that represented a significant amount of our sales for the year ended <em style="font: inherit;"> September 30, 2024</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1893606	usd
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1163360	usd
CY2024	ycbd	Net Income Loss Including Impairment NetIncomeLossIncludingImpairment	3700000	usd
CY2024Q3	ycbd	Working Capital WorkingCapital	1100000	usd
CY2024	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	0	usd
CY2023	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-700000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1534718	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2782680	usd
CY2024Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	830469	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1397034	usd
CY2024Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	-0	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	126742	usd
CY2024Q3	ycbd	Prepaid Inventory PrepaidInventory	159006	usd
CY2023Q3	ycbd	Prepaid Inventory PrepaidInventory	182675	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	2524193	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4235647	usd
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown	921314	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2358767	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2175219	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1904499	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1458640	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	454268	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	716579	usd
CY2024	us-gaap	Depreciation Excluding Lessor Asset Under Operating Lease DepreciationExcludingLessorAssetUnderOperatingLease	452326	usd
CY2023	us-gaap	Depreciation Excluding Lessor Asset Under Operating Lease DepreciationExcludingLessorAssetUnderOperatingLease	404280	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	13219000	usd
CY2024	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2024Q3	ycbd	Finitelived Intangible Asset Accumulated Impairment FinitelivedIntangibleAssetAccumulatedImpairment	17504000	usd
CY2023Q3	ycbd	Finitelived Intangible Asset Accumulated Impairment FinitelivedIntangibleAssetAccumulatedImpairment	17504000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3026831	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2329321	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2889580	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3219090	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	762457	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	733740	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	733740	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	569923	usd
CY2024Q3	ycbd	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	89720	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2889580	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	667000	usd
CY2024Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	4669000	usd
CY2024Q3	ycbd	Dividends Payable Quarterly Growth DividendsPayableQuarterlyGrowth	1000000	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3939057
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2960573
	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	64218
CY2023Q2	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	39533
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	55656
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	151.1
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M18D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7233
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.51
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	21124
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	88.12
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	41765
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	144.43
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M24D
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	8000
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.86
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5730
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	117.35
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	44035
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	123.58
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M20D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	44035
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	123.58
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y1M20D
CY2023	ycbd	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	40500
CY2023	ycbd	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	2.52
CY2023	ycbd	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	-0
CY2023	ycbd	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	ycbd	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	3395
CY2023	ycbd	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	242.55
CY2024	ycbd	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0
CY2024	ycbd	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	0
CY2024	ycbd	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	0
CY2024	ycbd	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	0
CY2024	ycbd	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	-1352
CY2024	ycbd	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	337.5
CY2024Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	48957
CY2024Q3	ycbd	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	337.5
CY2024Q3	ycbd	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm	P4Y25D
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	1328497	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	1421610	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y11M26D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0466	pure
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	99467	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	99467	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	771	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	98696	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-3700126	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22938209	usd
CY2024	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4004001	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002000	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7704127	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26940209	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4312546
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2022320
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4312546
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2022320
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.79
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.32
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.79
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.32
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.021	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.014	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.119	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.015	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.002	pure
CY2024	ycbd	Effective Income Tax Rate Reconciliation Change In Value Of Convertible Debt EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt	-0.025	pure
CY2023	ycbd	Effective Income Tax Rate Reconciliation Change In Value Of Convertible Debt EffectiveIncomeTaxRateReconciliationChangeInValueOfConvertibleDebt	0	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.33	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.211	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2024Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15478000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14784000	usd
CY2024Q3	ycbd	Right Of Use Liability RightOfUseLiability	22000	usd
CY2023Q3	ycbd	Right Of Use Liability RightOfUseLiability	824000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	702000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	702000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	77000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	481000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	521000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	176000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	105000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	573000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	180000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	101000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	87000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	57000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	45000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	0	usd
CY2023Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	28000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	146000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	43000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	13000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	39000	usd
CY2024Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17826000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17367000	usd
CY2024Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	76000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	107000	usd
CY2024Q3	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	19000	usd

Files In Submission

Name	View Source	Status
0001437749-24-037840-index-headers.html	Edgar Link	pending
0001437749-24-037840-index.html	Edgar Link	pending
0001437749-24-037840.txt	Edgar Link	pending
0001437749-24-037840-xbrl.zip	Edgar Link	pending
c02.jpg	Edgar Link	pending
c03.jpg	Edgar Link	pending
cbd01.jpg	Edgar Link	pending
ex_722096.htm	Edgar Link	pending
ex_722097.htm	Edgar Link	pending
ex_722098.htm	Edgar Link	pending
ex_722099.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ycbd-20240930.xsd	Edgar Link	pending
ycbd20240930c_10k.htm	Edgar Link	pending
ycbd_10klogo.jpg	Edgar Link	pending
ycbd-20240930_lab.xml	Edgar Link	unprocessable
ycbd-20240930_def.xml	Edgar Link	unprocessable
ycbd-20240930_pre.xml	Edgar Link	unprocessable
ycbd20240930c_10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
ycbd-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$YCBD
cbdMD, Inc. Stock $ycbd

2024 Q4 Form 10-K Financial Statement

#000143774924037840 Filed on December 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YCBD cbdMD, Inc. Stock $ycbd

2024 Q4 Form 10-K Financial Statement

#000143774924037840 Filed on December 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YCBD
cbdMD, Inc. Stock $ycbd